- ... protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058. Lancet. 2006; 368 ( ...
- ... used to treat diabetes (most often when overdosed) Nucleoside reverse transcriptase inhibitors used to treat HIV infection Propofol
- ... TDF, TAF is a prodrug of tenofovir, a nucleoside reverse transcriptase inhibitor of HIV. However, TAF is transported into peripheral ...
- ... who received one or more of the preferred nucleoside reverse transcriptase inhibitors for use in pregnancy (abacavir, lamivudine, tenofovir, or ...
- ... in risk of stillbirth. Tenofovir is a preferred nucleoside reverse transcriptase inhibitor for use in pregnancy in most, but not ...
- ... Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors J Natl Med Assoc Asad, ...
- ... al.: A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. ...
- ... with your health provider.Medications for HIV/AIDS (Nucleoside reverse transcriptase inhibitors (NRTIs))Taking horsetail with NRTIs might reduce the ...
- ... B* Martin Hirsch and Joep Lange ANTIRETROVIRAL THERAPIES NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS ZIDOVUDINE USE IN ASYMPTOMATICS: Results were presented of ...
- ... based pharmaceutical companies are continuing research with non-nucleoside reverse transcriptase inhibitors, protease inhibitors, tat inhibitors, and nucleoside reverse transcriptase ...
109 results